论文部分内容阅读
现据日本“医药品产业研究所”的资料将日、美、英、法、德、意等6个主要资本主义国家1973年上市新药情况汇总制成一览表,译刊于下,供读者参考。由附表可见:这6个国家1973年共上市新药155种,但除去重复品种及已在其他国家先行销售者外,实际上新品种只有27个。其中有些在我国也已生产或试制(附有※号)。 1973年上市新药中,比较受人注目的主要是: 日本的磺苄青霉素(Lilacillin)——抗菌素; 美国的7β,11α-二甲基睾丸酮(Methosard)——抗癌药; 英国的Nolvadex——抗癌药法国的苯甲酰苯丙酸(Ketoprofen)——消炎镇痛药等。对资本主义国家新药情况进行分析研究的结果可以看出,近年来新出现的品种已愈来愈少。
According to Japan’s “Pharmaceutical Industry Institute,” the data will be Japan, the United States, Britain, France, Germany, Italy and other major capitalist countries in six countries listed in 1973 a summary of the situation of new drugs made a list, the translation of the next, for readers reference. As shown in the attached table, 155 new drugs were listed in these six countries in 1973. However, only 27 new varieties were actually excluded except for the repeated varieties and those already sold in other countries. Some of them are also produced or trial-produced in our country (with ※ sign). Listed in the new drugs in 1973, the more notable are: Lilacillin - antibiotics in Japan; 7β, 11α - Methosard - anticancer drugs in the United States; Nolvadex in the United Kingdom - Anti-cancer drugs French benzoyl benzene acid (Ketoprofen) - anti-inflammatory analgesics. The results of the analysis and study of the new drugs in capitalist countries show that the number of newly emerged species has been decreasing in recent years.